What nasal sprays are safe to use during pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Safest Nasal Sprays During Pregnancy

Intranasal corticosteroid sprays are safe and recommended during pregnancy, with budesonide being the preferred first choice due to its Pregnancy Category B classification and extensive human safety data. 1

Primary Recommendations

First-Line: Intranasal Corticosteroids

Budesonide nasal spray is the safest option when starting treatment during pregnancy, as it has:

  • Pregnancy Category B classification
  • Extensive human safety data demonstrating no increased risk of major malformations, preterm delivery, low birth weight, or pregnancy-induced hypertension 1
  • The most robust evidence base among all intranasal corticosteroids 1

If already using another intranasal corticosteroid before pregnancy (such as fluticasone propionate, mometasone, or beclomethasone), it is reasonable to continue the same medication that has been controlling symptoms effectively 1. Meta-analyses show no convincing evidence of congenital defects with these agents 1.

The 2020 EPOS guidelines specifically recommend continuing nasal corticosteroid sprays for chronic rhinosinusitis maintenance during pregnancy 2.

Second-Line: Sodium Cromolyn

Sodium cromolyn nasal spray is a safe alternative with:

  • Pregnancy Category B classification
  • Reassuring human and animal gestational data
  • Topical application with minimal systemic absorption 1

Limitation: Requires 4 times daily dosing and has reduced efficacy compared to intranasal corticosteroids, limiting patient acceptance 1.

What to Avoid

Topical Decongestants

Avoid or use only short-term (up to 7 days maximum). The safety data for intranasal decongestants (oxymetazoline, phenylephrine) during pregnancy has not been adequately studied 1. While they may have a better safety profile than oral decongestants for first trimester use, data remain insufficient 1.

Intranasal Antihistamines

Avoid during pregnancy. Limited data exist for azelastine and levocetirizine, and these should not be used 3.

Off-Label Formulations

Do not use budesonide irrigations or corticosteroid nasal drops during pregnancy—these are off-label uses without safety data 4.

Key Safety Considerations

Timing matters: First trimester exposure carries the greatest theoretical concern for teratogenicity, though modern intranasal corticosteroids have not demonstrated this risk in human studies 1.

Dose optimization: Use the lowest effective dose to maintain symptom control 1.

Systemic absorption: Intranasal corticosteroids have much lower systemic exposure compared to oral or inhaled corticosteroids, making them particularly safe 1.

Breastfeeding: Intranasal corticosteroids are compatible with breastfeeding 5.

Non-Pharmacologic First Option

Before any medication, consider hypertonic saline nasal rinses—these are completely safe with no fetal risk and demonstrate significant efficacy for pregnancy-induced rhinitis and seasonal allergic rhinitis 6, 7. One randomized study showed statistically significant improvement in rhinitis scores and reduced antihistamine use in pregnant women using hypertonic saline 3 times daily 7.

Common Pitfalls to Avoid

  • Don't withhold intranasal corticosteroids due to pregnancy concerns—the evidence strongly supports their safety, and undertreated maternal symptoms may pose greater risks 4
  • Don't switch medications unnecessarily—if a patient is well-controlled on a specific intranasal corticosteroid pre-pregnancy, continuation is appropriate 1
  • Don't use intranasal triamcinolone—one study found a significant association with respiratory tract defects 8
  • Don't prescribe oral decongestants, especially in the first trimester, due to associations with gastroschisis and small intestinal atresia 1

References

Guideline

the diagnosis and management of rhinitis: an updated practice parameter.

Journal of Allergy and Clinical Immunology, 2008

Research

Allergy Medications During Pregnancy.

The American journal of the medical sciences, 2016

Research

Over-the-Counter Medications in Pregnancy.

American family physician, 2023

Research

Nasal lavage in pregnant women with seasonal allergic rhinitis: a randomized study.

International archives of allergy and immunology, 2010

Research

Safety of intranasal corticosteroid sprays during pregnancy: an updated review.

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.